Does BIMEKIZUMAB Cause Stent placement? 10 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Stent placement have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 0.4% of all adverse event reports for BIMEKIZUMAB.
10
Reports of Stent placement with BIMEKIZUMAB
0.4%
of all BIMEKIZUMAB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Stent placement From BIMEKIZUMAB?
Of the 10 reports, 8 (80.0%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which BIMEKIZUMAB Alternatives Have Lower Stent placement Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN